Trade Curis, Inc. - CRIS stock price

1.2901
-0.06%
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

CRIS price history

Date Close Change Chg% Open Min. Max.
2022-09-30 1.3449 -0.0050 -0.37 1.3499 1.2899 1.3649
2022-09-30 1.3599 -0.0300 -2.16 1.3899 1.3449 1.3899
2022-09-30 1.3799 -0.0400 -2.82 1.4199 1.3699 1.4549
2022-09-30 1.4049 -0.0400 -2.77 1.4449 1.3949 1.4449
2022-09-30 1.4699 0.0550 3.89 1.4149 1.4099 1.4699
2022-09-30 1.4449 -0.0400 -2.69 1.4849 1.4299 1.5599
2022-09-30 1.4799 -0.0450 -2.95 1.5249 1.3949 1.5299
2022-09-30 1.5299 -0.0200 -1.29 1.5499 1.5099 1.5849
2022-09-30 1.5849 0.0300 1.93 1.5549 1.5299 1.5999
2022-09-30 1.5549 -0.0300 -1.89 1.5849 1.4999 1.5999
2022-09-30 1.5399 -0.0250 -1.60 1.5649 1.5049 1.6349
2022-09-30 1.6049 -0.0800 -4.75 1.6849 1.5899 1.6849

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

iOS
4,7
12 127 reviews
Android
4,1
9 795 reviews
Go help.dzengi.com
Dzengi Exchange
Trade BTC & tokenized stocks